[go: up one dir, main page]

CN103830783B - A perfusion decision system for extracorporeal circulation - Google Patents

A perfusion decision system for extracorporeal circulation Download PDF

Info

Publication number
CN103830783B
CN103830783B CN201410085588.5A CN201410085588A CN103830783B CN 103830783 B CN103830783 B CN 103830783B CN 201410085588 A CN201410085588 A CN 201410085588A CN 103830783 B CN103830783 B CN 103830783B
Authority
CN
China
Prior art keywords
decision
perfusion
pai
waveform
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410085588.5A
Other languages
Chinese (zh)
Other versions
CN103830783A (en
Inventor
常宇
张娅
高斌
曾毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing University of Technology
Original Assignee
Beijing University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing University of Technology filed Critical Beijing University of Technology
Priority to CN201410085588.5A priority Critical patent/CN103830783B/en
Publication of CN103830783A publication Critical patent/CN103830783A/en
Application granted granted Critical
Publication of CN103830783B publication Critical patent/CN103830783B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/04Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

A kind of Cardiopulmonary bypass decision system, belongs to biomedical engineering technology field, mainly comprises decision-making module and detection module.Decision-making module, according to the data of detection module acquisition and processing, comprises output pressure and the blood flow of parameters of left ventricular function and oxygen supply index and outer circulation filling system, calculates perfusion subsidiary index number.This perfusion subsidiary index number represents the ratio of the acting of external counterpulsation system and patient's heart perfusion acting, and perfusion subsidiary index number value is higher, and the energy that external counterpulsation system provides for patient is higher.Decision-making module judges according to the parameters of left ventricular function of acquisition module collection and oxygen supply index, makes a policy: if index is within normal range, then pouring into subsidiary index number is recommendation, namely with reference to decision value; If index is outside normal range, then make warning.The reference decision value that doctor or control system propose according to decision-making module, selects to perform.By with reference to control agent outer filling flow based on decision value, the psychological need of patient can be adapted to, reduce complication.

Description

一种体外循环灌注决策系统A perfusion decision system for extracorporeal circulation

技术领域technical field

本发明涉及一种体外循环灌注决策系统,属于生物医学工程领域。The invention relates to an extracorporeal circulation perfusion decision-making system, which belongs to the field of biomedical engineering.

背景技术Background technique

体外循环灌注系统是外科手术中常用的辅助手段。国际上,卡迪欧嘉德医学公司的动脉装置、系统和方法CN201080025371.5,采用一种吸取腔布置借此以吸取流速提供离开所述主动脉的吸取流。可以同时且选择性地控制所述目标灌注流速和所述吸取流速,但是这种流量控制没有将患者的生理参数考虑进去。兰德有限公司的监测心肺分流术过程中医疗流体的体外循环和灌注的系统CN200710093658.1,监测和控制血泵的血流循环回路,但是其监控参数没有反馈到灌注血泵的控制。国内,中国人民解放军第四军医大学的一种体外循环整体灌注系统CN201220067806.9,也没有实现根据患者生理参数控制灌注流量。Extracorporeal circulation perfusion system is a commonly used auxiliary means in surgical operations. Internationally, the arterial device, system and method CN201080025371.5 of Cardio-Guard Medical Company adopts a suction lumen arrangement to provide a suction flow leaving the aorta at a suction flow rate. The target perfusion flow rate and the suction flow rate can be controlled simultaneously and selectively, but this flow control does not take into account the patient's physiological parameters. Rand Co., Ltd. CN200710093658.1, a system for monitoring the extracorporeal circulation and perfusion of medical fluid during cardiopulmonary bypass, monitors and controls the blood circulation circuit of the blood pump, but its monitoring parameters are not fed back to the control of the perfusion blood pump. In China, CN201220067806.9, an integrated extracorporeal circulation perfusion system developed by the Fourth Military Medical University of the Chinese People's Liberation Army, has not realized the control of perfusion flow according to the patient's physiological parameters.

目前的体外灌注系统的灌注流量是依靠医生经验控制,灌注流量没有耦合患者的生理参数变化综合考虑,因此会有过灌注或灌注不足的危险。The perfusion flow rate of the current extracorporeal perfusion system is controlled by the doctor's experience, and the perfusion flow rate is not coupled with the patient's physiological parameter changes, so there is a risk of over-perfusion or under-perfusion.

华中科技大学的一种基于自相关建模法的低灌注血氧饱和度测量方法CN103027690A,虽然设计了一种测量血流灌注指数的方法,但是该指数仅反映了血流的脉动性,无法表示体外灌注流量与患者自身心脏灌注的比值关系,无法为调节体外灌注流量提供依据。A low perfusion oxygen saturation measurement method based on autocorrelation modeling method CN103027690A of Huazhong University of Science and Technology. Although a method for measuring blood perfusion index is designed, this index only reflects the pulsation of blood flow and cannot express The ratio relationship between in vitro perfusion flow and patient's own heart perfusion cannot provide a basis for adjusting in vitro perfusion flow.

灌注过程中,生理参数如心排量,心率,血压等和体外灌注的流量实时相关,这些参数会随着血泵旋转造成的流量变化而变化。在控制血泵决策中,这些参数也是重要的影响因素。During the perfusion process, physiological parameters such as cardiac output, heart rate, blood pressure, etc. are related to the perfusion flow in vitro in real time, and these parameters will change with the flow change caused by the rotation of the blood pump. These parameters are also important influencing factors in the decision to control the blood pump.

发明内容Contents of the invention

为了能够根据患者的生理参数调节体外灌注流量,减少并发症,本发明提供一种体外循环灌注决策系统,使灌注量维持在适合患者状态的范围。In order to adjust the extracorporeal perfusion flow rate according to the patient's physiological parameters and reduce complications, the present invention provides an extracorporeal circulation perfusion decision-making system to maintain the perfusion volume in a range suitable for the patient's state.

为了实现上述目的,本发明采取了如下技术方案:In order to achieve the above object, the present invention has taken the following technical solutions:

一种体外循环灌注决策系统,系统包括检测模块和决策模块,所述检测模块循环采集患者的生理数据和体外灌注系统的参数,患者的生理数据包括心排量、心率、血压、静脉血氧饱和度和动脉血氧饱和度,体外灌注系统的参数包括输出压力和流量,并且检测模块将其中的心排量、血压、输出压力、流量分别拟合成动脉压的波形、动脉血流量的波形、体外循环灌注血泵的出口压力波形、体外循环灌注血泵的灌注血流量的波形,同时将上述数据显示出来并送到所述决策模块;所述决策模块根据式An extracorporeal circulation perfusion decision-making system, the system includes a detection module and a decision-making module, the detection module cyclically collects the patient's physiological data and parameters of the extracorporeal perfusion system, the patient's physiological data includes cardiac output, heart rate, blood pressure, venous oxygen saturation degree and arterial blood oxygen saturation, the parameters of the extracorporeal perfusion system include output pressure and flow, and the detection module fits the cardiac output, blood pressure, output pressure, and flow into the waveform of arterial pressure, arterial blood flow, The outlet pressure waveform of the extracorporeal circulation perfusion blood pump, the waveform of the perfusion blood flow of the extracorporeal circulation perfusion blood pump, and the above data are displayed at the same time and sent to the decision-making module; the decision-making module is based on the formula

PP AA II (( ωω )) == 11 TT cc ∫∫ 00 TT cc (( PP pp (( tt )) Ff pp (( tt )) PP aa pp (( tt )) Ff aa pp (( tt )) )) dd tt

得到参考决策PAI,并将参考决策PAI显示出来,或者同时输出给体外灌注系统;Get the reference decision PAI, and display the reference decision PAI, or output it to the in vitro perfusion system at the same time;

式中,PAI(ω)——体外循环灌注和心脏灌注的做功关系,In the formula, PAI(ω)—work relationship between extracorporeal circulation perfusion and cardiac perfusion,

Pp(t)——体外循环灌注血泵的出口压力波形,P p (t)——the outlet pressure waveform of extracorporeal circulation perfusion blood pump,

Fp(t)——体外循环灌注血泵的灌注血流量的波形,F p (t)—the waveform of the perfusion blood flow of the extracorporeal circulation perfusion blood pump,

Pap(t)——动脉压的波形,P ap (t) - waveform of arterial pressure,

Fap(t)——动脉血流量的波形,F ap (t)—the waveform of arterial blood flow,

Tc——心动周期,由心率得到;T c ——cardiac cycle, obtained from heart rate;

所述的静脉血氧饱和度和动脉血氧饱和度作为判别PAI(ω)是否为参考决策PAI的依据,如果动脉血氧饱和度>90%,静脉血氧饱和度维持在64~88%之间,PAI(ω)为推荐值,输出参考决策PAI。The venous blood oxygen saturation and arterial blood oxygen saturation are used as the basis for judging whether PAI(ω) is a reference decision-making PAI. If the arterial blood oxygen saturation is >90%, the venous blood oxygen saturation is maintained between 64% and 88%. , PAI(ω) is the recommended value, and the reference decision PAI is output.

以下面的条件为依据可以得到所述参考决策PAI的最佳值:The optimal value of the reference decision PAI can be obtained on the basis of the following conditions:

1)动脉血氧饱和度>90%,静脉血氧饱和度维持在64~88%之间;1) Arterial oxygen saturation >90%, and venous oxygen saturation maintained between 64% and 88%;

2)心率在根据公式118.1-(0.57×年龄)计算的值附近;2) The heart rate is near the value calculated according to the formula 118.1-(0.57×age);

3)心排量为4~7L/min或心排量平均值为4~6.5L/min;3) The cardiac output is 4-7L/min or the average cardiac output is 4-6.5L/min;

4)血压收缩压≤140mmHg(18.6kPa),舒张压≤90mmHg(12kPa)。4) Blood pressure systolic blood pressure ≤ 140mmHg (18.6kPa), diastolic blood pressure ≤ 90mmHg (12kPa).

本发明的有益效果在于:利用体外循环灌注决策系统可以根据患者的生理参数制定灌注决策,以此为基础调节体外灌注流量,适应患者的生理需求,减少并发症。The beneficial effect of the present invention is that: the extracorporeal circulation perfusion decision-making system can be used to make perfusion decisions according to the physiological parameters of patients, and based on this, the extracorporeal perfusion flow can be adjusted to meet the physiological needs of patients and reduce complications.

附图说明Description of drawings

图1是本发明一种体外循环灌注决策系统的结构示意图。Fig. 1 is a schematic structural diagram of an extracorporeal circulation perfusion decision-making system according to the present invention.

具体实施方式detailed description

下面结合附图1对本发明的的具体构成做详细说明。The specific structure of the present invention will be described in detail below in conjunction with accompanying drawing 1 .

体外循环灌注流量决策系统包括检测模块和决策模块,结构框图如图1所示。检测模块采集患者的生理数据和体外灌注系统的参数,并将数据传递给所述决策模块。生理数据包括患者心功能指标,如心排量、心率、血压和供氧指标(包括静脉血氧饱和度和动脉血氧饱和度)。体外灌注系统的参数包括输出压力和流量。决策模块接收检测模块的数据并进行计算,得出参考决策PAI。The extracorporeal circulation perfusion flow decision-making system includes a detection module and a decision-making module, and the structural block diagram is shown in Figure 1. The detection module collects the physiological data of the patient and the parameters of the extracorporeal perfusion system, and transmits the data to the decision-making module. Physiological data include indicators of cardiac function, such as cardiac output, heart rate, blood pressure, and oxygen supply indicators (including venous oxygen saturation and arterial oxygen saturation). The parameters of extracorporeal perfusion system include output pressure and flow. The decision-making module receives the data from the detection module and performs calculations to obtain the reference decision-making PAI.

其中,患者的心排量,心率,血压,血氧饱和度可采用常规检测手段获得,如多普勒流量传感器检测心排量,双有创压力传感器检测血压,心电电极检测心率,光电传感器检测血氧饱和度。Among them, the patient's cardiac output, heart rate, blood pressure, and blood oxygen saturation can be obtained by conventional detection methods, such as Doppler flow sensor to detect cardiac output, dual invasive pressure sensors to detect blood pressure, ECG electrodes to detect heart rate, photoelectric sensor Check blood oxygen saturation.

检测模块采用计算机和多路信号选择开关电路(如芯片CD4051构成的多路信号选择开关电路)构成,多通道数据采集模块依次将各路信号采集到计算机,并循环采集。计算机拟合出动脉压和血流量的波形,以及体外循环灌注血泵出口压力和流量的波形。The detection module is composed of a computer and a multi-channel signal selection switch circuit (such as a multi-channel signal selection switch circuit composed of a chip CD4051), and the multi-channel data acquisition module sequentially collects signals from various channels to the computer and collects them cyclically. The computer fits the waveforms of the arterial pressure and blood flow, as well as the waveforms of the outlet pressure and flow of the extracorporeal circulation perfusion blood pump.

决策模块可采用简单的单片机及其外围电路构成。通过编写程序,得到参考决策PAI。其原理如下:The decision-making module can be composed of a simple single-chip microcomputer and its peripheral circuits. By writing a program, the reference decision PAI is obtained. The principle is as follows:

为评价体外循环灌注和心脏灌注的做功关系,引入灌注辅助指数PAI(ω),描述二者之间的做功分配。决策模块中安装了计算PAI(ω)的算法程序,由公式In order to evaluate the work relationship between cardiopulmonary bypass perfusion and cardiac perfusion, the perfusion assistance index PAI(ω) was introduced to describe the work distribution between the two. The algorithm program for calculating PAI(ω) is installed in the decision-making module, which is determined by the formula

P A I ( ω ) = 1 T c ∫ 0 T c ( P p ( t ) F p ( t ) P a p ( t ) F a p ( t ) ) d t 得到; P A I ( ω ) = 1 T c ∫ 0 T c ( P p ( t ) f p ( t ) P a p ( t ) f a p ( t ) ) d t get;

式中,Pp(t)——体外循环灌注血泵的出口压力波形,In the formula, P p (t)——the outlet pressure waveform of extracorporeal circulation perfusion blood pump,

Fp(t)——体外循环灌注血泵的灌注血流量的波形,F p (t)—the waveform of the perfusion blood flow of the extracorporeal circulation perfusion blood pump,

Pap(t)——动脉压的波形,P ap (t) - waveform of arterial pressure,

Fap(t)——动脉血流量的波形,F ap (t)—the waveform of arterial blood flow,

Tc——心动周期。T c ——cardiac cycle.

由于出口压力和血流量的波形是体外循环灌注系统产生的,是可以调节的,由所述检测模块获得,从而PAI(ω)是一个随患者生理参数变化的个性化决策因子。PAI(ω)可以评价心脏与体外灌注系统的做功关系,描述二者之间的做功分配,单位是“%”,其正常范围在0%-100%内。当PAI(ω)<100%时,体外灌注系统处于部分辅助。当PAI(ω)=100%,体外灌注系统处于完全辅助。PAI(ω)值越高,体外灌注系统为患者提供的能量越高。Since the outlet pressure and blood flow waveforms are generated by the extracorporeal circulation perfusion system and can be adjusted, they are obtained by the detection module, so PAI(ω) is a personalized decision factor that changes with the patient's physiological parameters. PAI(ω) can evaluate the work relationship between the heart and the extracorporeal perfusion system, and describe the work distribution between the two. The unit is "%", and its normal range is within 0%-100%. When PAI(ω)<100%, the extracorporeal perfusion system is partially assisted. When PAI(ω)=100%, the extracorporeal perfusion system is fully assisted. The higher the PAI(ω) value, the higher the energy provided by the extracorporeal perfusion system to the patient.

决策模块根据检测模块采集的生理数据如心排量,心率,血压,血氧饱和度,计算参考决策,即PAI(ω)。当这些生理数据在正常值时,PAI(ω)为参考决策值PAI,医生或控制系统可以参考决策值PAI调节灌注量。如果生理数据不在正常范围内,决策模块则发出警告。决策模块PAI参照的生理参数的正常值如下:动脉血氧饱和度>90%,静脉血氧饱和度维持在64~88%之间;正常心跳频率范围在60-100/分,平均在75/分左右,心率正常值根据以下公式计算:118.1-(0.57×年龄);心排量的正常值为4~7L/min,心排量平均值为4~6.5L/min;血压收缩压≤140mmHg(18.6kPa),舒张压≤90mmHg(12kPa)。The decision-making module calculates a reference decision, namely PAI(ω), based on the physiological data collected by the detection module, such as cardiac output, heart rate, blood pressure, and blood oxygen saturation. When these physiological data are at normal values, PAI(ω) is the reference decision value PAI, and the doctor or the control system can refer to the decision value PAI to adjust the perfusion volume. If the physiological data is not within the normal range, the decision module issues a warning. The normal values of the physiological parameters referenced by the decision-making module PAI are as follows: arterial oxygen saturation >90%, venous oxygen saturation maintained between 64% and 88%; The normal value of heart rate is calculated according to the following formula: 118.1-(0.57×age); the normal value of cardiac output is 4-7L/min, and the average value of cardiac output is 4-6.5L/min; systolic blood pressure≤140mmHg (18.6kPa), diastolic pressure ≤ 90mmHg (12kPa).

Claims (2)

1. a Cardiopulmonary bypass decision system, system comprises detection module and decision-making module, it is characterized in that: the described physiological data of detection module circle collection patient and the parameter of external counterpulsation system, the physiological data of patient comprises heart stroke, heart rate, blood pressure, Svo2 and arterial oxygen saturation, the parameter of external counterpulsation system comprises output pressure and flow, and detection module is by heart stroke wherein, blood pressure, output pressure, flow fits to the waveform of arterial pressure respectively, the waveform of blood flow volume, the outlet pressure waveform of Cardiopulmonary bypass blood pump, the waveform of the perfusion blood flow of Cardiopulmonary bypass blood pump, simultaneously by the physiological data of above-mentioned all patients, the parameter of external counterpulsation system, and detection module matching waveform out shows and delivers to described decision-making module, described decision-making module is according to formula
P A I ( &omega; ) = 1 T c &Integral; 0 T c ( P p ( t ) F p ( t ) P a p ( t ) F a p ( t ) ) d t
Obtain with reference to decision-making PAI, and show with reference to decision-making PAI, or export to external counterpulsation system simultaneously;
In formula, the acting relation of PAI (ω)---Cardiopulmonary bypass and heart perfusion,
P pthe outlet pressure waveform of (t)---Cardiopulmonary bypass blood pump,
F pthe waveform of the perfusion blood flow of (t)---Cardiopulmonary bypass blood pump,
P apthe waveform of (t)---arterial pressure,
F apthe waveform of (t)---blood flow volume,
T c---cardiac cycle, is obtained by heart rate;
Described Svo2 and arterial oxygen saturation are as differentiating that whether PAI (ω) is the foundation with reference to decision-making PAI, if arterial oxygen saturation >90%, Svo2 maintains between 64 ~ 88%, PAI (ω) is recommendation, exports with reference to decision-making PAI.
2. a kind of Cardiopulmonary bypass decision system as claimed in claim 1, is characterized in that: the described foundation with reference to decision-making PAI is,
1) arterial oxygen saturation >90%, Svo2 maintains between 64 ~ 88%;
2) heart rate is near the value calculated according to formula 118.1-(0.57 × age);
3) heart stroke is 4 ~ 7L/min, and heart stroke meansigma methods is 4 ~ 6.5L/min;
4) blood pressure systolic pressure≤140mmHg (18.6kPa), diastolic pressure≤90mmHg (12kPa).
CN201410085588.5A 2014-03-10 2014-03-10 A perfusion decision system for extracorporeal circulation Expired - Fee Related CN103830783B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410085588.5A CN103830783B (en) 2014-03-10 2014-03-10 A perfusion decision system for extracorporeal circulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410085588.5A CN103830783B (en) 2014-03-10 2014-03-10 A perfusion decision system for extracorporeal circulation

Publications (2)

Publication Number Publication Date
CN103830783A CN103830783A (en) 2014-06-04
CN103830783B true CN103830783B (en) 2016-01-13

Family

ID=50794880

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410085588.5A Expired - Fee Related CN103830783B (en) 2014-03-10 2014-03-10 A perfusion decision system for extracorporeal circulation

Country Status (1)

Country Link
CN (1) CN103830783B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2533027B (en) * 2014-12-03 2020-06-03 Spectrum Medical Ltd Control system
CN113350599B (en) * 2015-05-13 2024-07-05 迈奎特心肺有限公司 Extracorporeal circulation system
CN107114358B (en) * 2017-06-14 2018-05-15 广州军区广州总医院 liver machine perfusion control system, method and device
CN108543120A (en) * 2018-02-05 2018-09-18 武汉大学 A kind of encephalic cerebrospinal fluid automatic drainage device
CN109498936B (en) * 2018-10-15 2021-02-05 北京工业大学 An oxygen supply decision-making system for extracorporeal life support
CN111631700B (en) * 2020-05-25 2021-08-10 华南理工大学 System for regulating blood pressure according to optimal blood pressure target value
CN117979884A (en) * 2021-07-27 2024-05-03 北京优理医疗器械有限公司 Perioperative management device, method and application based on muscle tissue oxygen monitoring
WO2023004587A1 (en) * 2021-07-27 2023-02-02 北京优理医疗器械有限公司 Management apparatus, method, and application for perioperative period based on haemodynamic monitoring

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4449538A (en) * 1982-01-25 1984-05-22 John Corbitt Medical-electronic body fluid accounting system
CN1578682A (en) * 2002-07-18 2005-02-09 日机装株式会社 Blood treatment device and method for blood treatment
CN1751749A (en) * 2004-09-24 2006-03-29 陈炳华 Hemoperfusion apparatus
CN101274110A (en) * 2007-03-30 2008-10-01 兰德有限公司 System for monitoring extracorporeal circulation and perfusion of medical fluid in heart lung bypass process
CN202459484U (en) * 2012-02-28 2012-10-03 中国人民解放军第四军医大学 Extracorporeal-circulation whole perfusion system
CN103027690A (en) * 2012-11-28 2013-04-10 华中科技大学 Hypoperfusion oxyhemoglobin saturation measuring method based on self-correlation modeling method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5964694A (en) * 1997-04-02 1999-10-12 Guidant Corporation Method and apparatus for cardiac blood flow assistance
US20050027231A1 (en) * 1999-02-12 2005-02-03 Lifebridge Medizintechnik Gmbh Mobile heart-lung machine
DE10159620C1 (en) * 2001-12-05 2003-08-14 Fresenius Medical Care De Gmbh Method and device for monitoring the supply of substitution fluid during extracorporeal blood treatment
WO2003057280A2 (en) * 2002-01-07 2003-07-17 Micromed Technology, Inc. Method and system for physiologic control of an implantable blood pump
CN1202871C (en) * 2003-04-18 2005-05-25 清华大学 Optimal non-constant speed control method for miniature axial flow type blood pumps
US8303482B2 (en) * 2004-09-07 2012-11-06 Micromed Method and system for physiologic control of a blood pump

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4449538A (en) * 1982-01-25 1984-05-22 John Corbitt Medical-electronic body fluid accounting system
CN1578682A (en) * 2002-07-18 2005-02-09 日机装株式会社 Blood treatment device and method for blood treatment
CN1751749A (en) * 2004-09-24 2006-03-29 陈炳华 Hemoperfusion apparatus
CN101274110A (en) * 2007-03-30 2008-10-01 兰德有限公司 System for monitoring extracorporeal circulation and perfusion of medical fluid in heart lung bypass process
CN202459484U (en) * 2012-02-28 2012-10-03 中国人民解放军第四军医大学 Extracorporeal-circulation whole perfusion system
CN103027690A (en) * 2012-11-28 2013-04-10 华中科技大学 Hypoperfusion oxyhemoglobin saturation measuring method based on self-correlation modeling method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
一种主动脉内血泵血流辅助指数的控制策略;谷凯云 等;《医用生物力学》;20120831;第27卷(第4期);403-408 *
基于两级级联神经网络估计血泵转速及压力变化对血流量的影响;轩艳姣;《中国组织工程研究与临床康复》;20110226;第15卷(第9期);1631-1634 *
基于主动脉内血泵的集中参数模型研究;谷凯云 等;《医用生物力学》;20110831;第26卷(第4期);367-372 *
基于心率的主动脉血泵流量控制;谷凯云;《中国组织工程研究与临床康复》;20110326;第15卷(第13期);2390-2393 *

Also Published As

Publication number Publication date
CN103830783A (en) 2014-06-04

Similar Documents

Publication Publication Date Title
CN103830783B (en) A perfusion decision system for extracorporeal circulation
WO2021208490A1 (en) Blood pressure measuring method and device based on deep neural network
CN101522096B (en) Method and system for non-invasive measurement of cardiac parameters
CN105286787B (en) The amount of liquid monitoring of nephrotic
CN106725396B (en) Non-invasive beat-to-beat blood pressure measuring device and method based on double pulse waves
JP2014518688A5 (en)
CN102119908B (en) Closed-loop external chest compression system
CN104921713B (en) A kind of myocardium blood oxygen state between supply and demand dynamic monitoring system and method for early warning based on heart rate and pulse
CN105848581A (en) Method and device for managing fluid volume in the body
JP2002177226A (en) Treatment and device for determining pulse transition time and external hemotherapy equipment
CN104055496B (en) A kind of method of estimation of the sports load level based on heart source property signal
CN204971245U (en) Human many parameter monitoring of vital sign system
CN104856659B (en) A kind of myocardium blood oxygen state between supply and demand dynamic monitoring system and method for early warning based on acceleration Yu pulse
CN103876723A (en) Method for obtaining blood pressure value by calculating pulse wave conduction time through non-invasive radial artery waves
CN110236508A (en) A kind of non-invasive blood pressure continuous monitoring method
US20220218928A1 (en) Method for evaluating volume responsiveness and medical device
CN107174225A (en) A kind of arm belt blood vessel physiologic parameter monitoring device
CN106725394A (en) A kind of blood pressure data harvester and method
WO2020132899A1 (en) Blood pressure and pulse detection system, and detection method and device therefor
JP4695646B2 (en) Non-invasive cardiac monitoring device and method
Mahmood et al. Development of blood pressure monitor by using capacitive pressure sensor and microcontroller
CN104688219A (en) Electrocardiosignal prediction method and electrocardiosignal prediction system
CN203576490U (en) Invasive blood pressure detection and analysis system
CN205041388U (en) Sphygmomanometry apparatus
CN114557684A (en) Wristwatch type pulse electrocardio synchronous acquisition display device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160113

Termination date: 20200310

CF01 Termination of patent right due to non-payment of annual fee